Data on comprehensive population-based surveillance of antimicrobial resistance is lacking.
In low-and middle-income countries, the challenges are high due to weak laboratory …

Carbapenemases are β-lactamase enzymes that hydrolyze a variety of β-lactams including
carbapenem and belong to different Ambler classes (A, B, D). These enzymes can be …

With the excessive genome plasticity, Acinetobacter baumannii can acquire and
disseminate antimicrobial resistance (AMR) genes often associated with mobile genetic …

Carbapenem-resistant Klebsiella pneumoniae (CRKP) seriously threaten the efficacy of
modern medicine with a high associated mortality rate and unprecedented transmission …

Objectives Co-transfer of carbapenem and amikacin resistance might contribute to the
evolution of extensively drug resistant (XDR) Acinetobacter baumannii. The current study …

Acinetobacter baumannii has become a major challenge to clinicians worldwide due to its
high epidemic potential and acquisition of antimicrobial resistance. This work aimed at …

Carbapenems—one of the important last-line antibiotics for the treatment of gram-negative
infections—are becoming ineffective for treating Acinetobacter baumannii infections. Studies …

Background: The rapid emergence of carbapenem resistant Acinetobacter baumannii
(CRAB) has resulted in an alarming situation worldwide. Realizing the dearth of literature on …

Background and aim The increasing number of nosocomial infections associated with
Acinetobacter baumannii (A. baumannii) is causing this bacterium to become a more …

Acinetobacter baumannii has emerged as one of the dominant nosocomial human
pathogens associated with high morbidity and mortality globally. Increased incidences of …